Letter to FDA Requesting Documents Relating to the Outbreak of Fungal Meningitis


Excerpt: In order to effectively and responsibly address the question of clarifying or enhancing FDA’s authority over compounding pharmacies, the committee must identify what happened at the New England Compounding Center (NECC), and why FDA did not use its authority to take enforcement action against NECC until October 2012, after the meningitis outbreak.

To read the letter, click here.

To read a related press release, click here.